Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China flag China · Delayed Price · Currency is CNY
10.52
-0.12 (-1.13%)
Feb 13, 2026, 3:04 PM CST

SHE:300434 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,0181,0661,1711,2001,006734.16
Other Revenue
36.0536.0538.0942.7947.7443.14
1,0541,1021,2091,2431,054777.3
Revenue Growth (YoY)
-7.43%-8.84%-2.69%17.95%35.53%-22.70%
Cost of Revenue
440.07473.18467.99480.74459.56359.85
Gross Profit
614.09629.17741.21761.87593.94417.45
Selling, General & Admin
390.19430.14429.02421.07419.15375.19
Research & Development
58.035050.0139.1837.4527.84
Other Operating Expenses
32.2220.122.4518.7417.6417.02
Operating Expenses
478.48500.79500.6481.06478.49425.08
Operating Income
135.61128.38240.61280.8115.45-7.63
Interest Expense
-1.09-1.32-0.67-0.46-0.02-0.17
Interest & Investment Income
4.745.3412.092.742.974.32
Currency Exchange Gain (Loss)
0.610.610.421.38-0.18-1.01
Other Non Operating Income (Expenses)
1.72-3.893.28-7.91-0.46-0.17
EBT Excluding Unusual Items
141.59129.12255.73276.56117.77-4.66
Impairment of Goodwill
---67.51--23.17-668.75
Gain (Loss) on Sale of Investments
-10.4-11.35-18.43-11.97-9.67-1.57
Gain (Loss) on Sale of Assets
0.04-0.020.2517.77-0-0.04
Asset Writedown
-4.15-4.87-0.78-1.4-2.72-0.05
Other Unusual Items
25.299.787.769.5811.349.97
Pretax Income
152.37122.66177.02290.5493.54-665.09
Income Tax Expense
24.7434.156.3177.4927.4319.38
Earnings From Continuing Operations
127.6388.56120.71213.0566.1-684.47
Minority Interest in Earnings
2.773.25.495.740.38-3.19
Net Income
130.491.76126.2218.7966.48-687.66
Net Income to Common
130.491.76126.2218.7966.48-687.66
Net Income Growth
186.30%-27.29%-42.32%229.10%--
Shares Outstanding (Basic)
390399407405391402
Shares Outstanding (Diluted)
390399407405391402
Shares Change (YoY)
-7.40%-2.00%0.48%3.60%-2.75%0.26%
EPS (Basic)
0.330.230.310.540.17-1.71
EPS (Diluted)
0.330.230.310.540.17-1.71
EPS Growth
209.18%-25.81%-42.59%217.65%--
Free Cash Flow
133.685.2385.04268.8951.0397.91
Free Cash Flow Per Share
0.340.210.210.660.130.24
Dividend Per Share
0.0690.0690.110---
Dividend Growth
-37.27%-37.27%----
Gross Margin
58.25%57.07%61.30%61.31%56.38%53.71%
Operating Margin
12.86%11.65%19.90%22.60%10.96%-0.98%
Profit Margin
12.37%8.32%10.44%17.61%6.31%-88.47%
Free Cash Flow Margin
12.67%7.73%7.03%21.64%4.84%12.60%
EBITDA
243.82230.38334.33371.87202.4178.44
EBITDA Margin
23.13%20.90%27.65%29.93%19.21%10.09%
D&A For EBITDA
108.2110293.7291.0686.9686.07
EBIT
135.61128.38240.61280.8115.45-7.63
EBIT Margin
12.86%11.65%19.90%22.60%10.96%-0.98%
Effective Tax Rate
16.24%27.80%31.81%26.67%29.33%-
Revenue as Reported
1,0541,1021,2091,2431,054777.3
Advertising Expenses
-69.5774.9959.769.5951.49
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.